[go: up one dir, main page]

AU8852301A - Compositions and methods for inducing vasorelaxation - Google Patents

Compositions and methods for inducing vasorelaxation

Info

Publication number
AU8852301A
AU8852301A AU8852301A AU8852301A AU8852301A AU 8852301 A AU8852301 A AU 8852301A AU 8852301 A AU8852301 A AU 8852301A AU 8852301 A AU8852301 A AU 8852301A AU 8852301 A AU8852301 A AU 8852301A
Authority
AU
Australia
Prior art keywords
compositions
methods
inducing vasorelaxation
vasorelaxation
inducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU8852301A
Other languages
English (en)
Inventor
Meir S Sacks
Knox Van Dyke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU8852301A publication Critical patent/AU8852301A/xx
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU8852301A 2000-09-01 2001-08-29 Compositions and methods for inducing vasorelaxation Pending AU8852301A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65388700A 2000-09-01 2000-09-01
PCT/US2001/026983 WO2002017898A2 (en) 2000-09-01 2001-08-29 Compositions and methods for inducing vasorelaxation

Publications (1)

Publication Number Publication Date
AU8852301A true AU8852301A (en) 2002-03-13

Family

ID=24622672

Family Applications (1)

Application Number Title Priority Date Filing Date
AU8852301A Pending AU8852301A (en) 2000-09-01 2001-08-29 Compositions and methods for inducing vasorelaxation

Country Status (2)

Country Link
AU (1) AU8852301A (xx)
WO (1) WO2002017898A2 (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2294543T3 (es) 2003-07-09 2008-04-01 The Government Of The United States Of America, As Represented By The Secretary, Department Of Heal Uso de sales de nitrilo para el tratamiento de afecciones cardiovasculares.
SI3138566T1 (sl) 2003-11-17 2022-04-29 Biomarin Pharmaceutical Inc. Postopki in sestavki za zdravljenje presnovnih motenj
JP2006206521A (ja) * 2005-01-28 2006-08-10 Univ Of Tokyo 一酸化窒素供与体としてのｎ−ニトロソアミン化合物
WO2006125123A2 (en) 2005-05-19 2006-11-23 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
US8642093B2 (en) 2007-10-30 2014-02-04 The Invention Science Fund I, Llc Methods and systems for use of photolyzable nitric oxide donors
US8221690B2 (en) 2007-10-30 2012-07-17 The Invention Science Fund I, Llc Systems and devices that utilize photolyzable nitric oxide donors
US20090112197A1 (en) 2007-10-30 2009-04-30 Searete Llc Devices configured to facilitate release of nitric oxide
US7862598B2 (en) 2007-10-30 2011-01-04 The Invention Science Fund I, Llc Devices and systems that deliver nitric oxide
WO2008080194A1 (en) * 2006-12-29 2008-07-10 The University Of Queensland Pain-relieving compositions and uses therefor
US8822509B2 (en) 2006-12-29 2014-09-02 The University Of Queensland Pain-relieving compositions and uses therefor
US8980332B2 (en) 2007-10-30 2015-03-17 The Invention Science Fund I, Llc Methods and systems for use of photolyzable nitric oxide donors
US7897399B2 (en) 2007-10-30 2011-03-01 The Invention Science Fund I, Llc Nitric oxide sensors and systems
US10080823B2 (en) 2007-10-30 2018-09-25 Gearbox Llc Substrates for nitric oxide releasing devices
US7846400B2 (en) 2007-10-30 2010-12-07 The Invention Science Fund I, Llc Substrates for nitric oxide releasing devices
US8877508B2 (en) 2007-10-30 2014-11-04 The Invention Science Fund I, Llc Devices and systems that deliver nitric oxide
EP2456432B1 (en) 2009-07-22 2024-02-28 University of Massachusetts Compositions to reduce oxidative stress
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
WO2023283332A1 (en) * 2021-07-07 2023-01-12 Emory University Uses of arginase inhibitors for managing kidney disease and cardiovascular conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5852058A (en) * 1993-06-11 1998-12-22 The Board Of Trustees Of The Leland Stanford Junior University Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
WO1999038507A1 (en) * 1998-01-30 1999-08-05 David George Le Couteur Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
US6635273B1 (en) * 1999-10-29 2003-10-21 Trustees Of Boston University Methods of treating vascular diseases characterized by nitric oxide insufficiency

Also Published As

Publication number Publication date
WO2002017898A2 (en) 2002-03-07
WO2002017898A3 (en) 2002-07-04

Similar Documents

Publication Publication Date Title
PL351552A1 (en) Gypsum compositions and related methods
HUP0301413A3 (en) Vaccine compositions
HUP0302117A3 (en) Vaccine composition
AU2002357119A8 (en) Mitocidal compositions and methods
AU8911801A (en) Improved nanocomposite compositions and methods for making and using same
GB0020089D0 (en) Vaccine Composition
IL151781A0 (en) Methods and compositions for rna interference
AU4570901A (en) Biocidal methods and compositions
AU7013501A (en) Methods and composition for oral vaccination
AU8852301A (en) Compositions and methods for inducing vasorelaxation
AU6832101A (en) Composition and method
AU4163402A (en) Composition and method
GB0024200D0 (en) Component vaccine
AU4215901A (en) Methods and compositions for immunoregulation
AU2002357748A8 (en) Osteopontin-related compositions and methods
IL154267A0 (en) Neuroprotective 2-pyridinamine compositions and related methods
GB0014975D0 (en) Waco
IL161553A0 (en) Methods and compositions for inducing tumor-specific cytotoxicity
IL153487A0 (en) Pharmaceutical compositions and methods for use
AU2002366809A8 (en) Syn3 compositions and methods
GB0009609D0 (en) Therapeutic compositions
IL153897A0 (en) Pharmaceutical compositions and methods for use
GB0030857D0 (en) Therapeutic compositions
AU1182402A (en) Methods and compositions for enhancing angiogenesis
GB2370247B (en) Improved vice